World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
84
Citations
26032
World Ranking
1370
National Ranking
89

Robert Zeiser publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Robert Zeiser sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 416 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Robert Zeiser D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert Zeiser sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 84 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Robert Zeiser is affiliated with the University of Freiburg in Germany and has contributed extensively to the field of medicine, with a particular focus on hematology and immunology. Their research spans multiple subfields including oncology, genetics, and molecular biology, reflecting a broad scope within medical science.

The scientist has been involved in research topics centered on hematopoietic stem cell transplantation, immune cell function and interaction, and acute myeloid leukemia. Other notable areas of work include chronic myeloid leukemia treatments, CAR-T cell therapy research, acute lymphoblastic leukemia research, and T-cell and B-cell immunology.

Frequent collaborators in Robert Zeiser's work include Geoffroy Andrieux, Melanie Boerries, Justus Duyster, Ralph Wäsch, and Lukas M. Braun. The volume of their joint work suggests ongoing cooperative efforts within their research community.

The following publication venues are where Robert Zeiser has frequently published:

  • Blood
  • Bone Marrow Transplantation
  • Transplantation and Cellular Therapy
  • Frontiers in Immunology
  • Blood Advances

Several recent papers involving Robert Zeiser include the following:

  • Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease, 2020, New England Journal of Medicine
  • Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease, 2021, New England Journal of Medicine

Other influential works listed in their research environment include:

  • Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN), 2020, Journal of Clinical Oncology
  • Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation, 2020, The Lancet Haematology
  • Immune modulatory effects of oncogenic KRAS in cancer, 2020, Nature Communications

Best Publications

  • Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy

    Robert Zeiser;Bruce R Blazar

  • Origin, fate and dynamics of macrophages at central nervous system interfaces.

    Tobias Goldmann;Peter Wieghofer;Marta Joana Costa Jordão;Fabiola Prutek

  • Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

    Robert Zeiser;Nikolas von Bubnoff;Jason Butler;Mohamad Mohty

  • Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets.

    Robert Zeiser;Bruce R Blazar

  • Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

    R. Zeiser;A. Burchert;C. Lengerke;M.M. Verbeek

  • Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production

    Robert S Zeiser;Vu H Nguyen;Andreas Beilhack;Martin Buess

  • Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)

    Andreas Burchert;Gesine Bug;Lea V. Fritz;Jürgen Finke

  • Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

    Olaf Penack;Monia Marchetti;Tapani Ruutu;Mahmoud Aljurf

  • Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R

    Konrad Wilhelm;Jayanthi Ganesan;Tobias Müller;Christoph Dürr

  • Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment

    Georgy Mikhaylov;Ursa Mikac;Anna A. Magaeva;Volya I. Itin

  • Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease.

    Silvia Spoerl;Nimitha R. Mathew;Michael Bscheider;Annette Schmitt-Graeff

  • Differential impact of mammalian target of rapamycin inhibition on CD4 + CD25 + Foxp3 + regulatory T cells compared with conventional CD4 + T cells

    Robert Zeiser;Dennis B. Leveson-Gower;Elizabeth A. Zambricki;Neeraja Kambham

  • Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

    Cristina Toffalori;Laura Zito;Valentina Gambacorta;Michela Riba

  • CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation

    Kavya Rakhra;Pavan Bachireddy;Tahera Zabuawala;Robert Zeiser

  • Immunodominance and functional alterations of tumor‐associated antigen‐specific CD8+ T‐cell responses in hepatocellular carcinoma

    Tobias Flecken;Nathalie Schmidt;Sandra Hild;Emma Gostick

  • Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion

    Anna M. Paczulla;Kathrin Rothfelder;Simon Raffel;Simon Raffel;Martina Konantz

  • Continuous T Cell Receptor Signals Maintain a Functional Regulatory T Cell Pool

    J. Christoph Vahl;Christoph Drees;Klaus Heger;Sylvia Heink

  • Immune modulatory effects of oncogenic KRAS in cancer

    Shaima’a Hamarsheh;Olaf Groß;Olaf Groß;Tilman Brummer;Tilman Brummer;Robert Zeiser

  • Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage

    Lukas Schwab;Luise Goroncy;Senthilnathan Palaniyandi;Sanjivan Gautam

  • Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

    Nimitha R Mathew;Nimitha R Mathew;Francis Baumgartner;Lukas Braun;David O'Sullivan

  • In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation.

    Vu H. Nguyen;Robert Zeiser;Daniel L. daSilva;Daisy S. Chang

Frequent Co-Authors

Jürgen Finke
Jürgen Finke University of Freiburg
Robert S. Negrin
Robert S. Negrin Stanford University
Bruce R. Blazar
Bruce R. Blazar University of Minnesota
Dietmar Pfeifer
Dietmar Pfeifer University of Freiburg
Marie Follo
Marie Follo University of Freiburg
Melanie Boerries
Melanie Boerries University of Freiburg
Marco Idzko
Marco Idzko Medical University of Vienna
Michael Lübbert
Michael Lübbert University of Freiburg
Gérard Socié
Gérard Socié Université Paris Cité
Geoffrey R. Hill
Geoffrey R. Hill Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their careers in immunology, exploring related online degrees and career pathways can open many doors. Many professionals consider pursuing a Doctorate in Nursing, and understanding the doctorate in nursing salary can help gauge the long-term benefits of such a commitment. This degree offers specialized knowledge that complements immunological expertise, especially in clinical and research settings.

Nurses aiming to transition within advanced practice roles might explore an fnp to acnp bridge program online. This pathway allows Family Nurse Practitioners to shift focus toward acute care, which often intersects with immunology through managing complex immune-related conditions.

Additionally, accelerated programs can fast-track credentials for healthcare professionals. The accelerated nurse practitioner program options are ideal for ambitious students seeking efficient entry into advanced practice with a focus that may align with immunology specialties.

For those beginning their journey, online rn programs for non nurses provide accessible routes into nursing careers. These programs lay a strong foundation in clinical knowledge, which is crucial for anyone interested in immunology-driven healthcare roles.

Best Scientists Citing Robert Zeiser

Trending Scientists

Recently Published Articles